Search results
Author(s):
Eleftherios M Kallergis
,
Emmanuel N Simantirakis
Added:
4 months ago
Author(s):
Zhaohui Qiu
,
Xianhao Wu
,
Haiyan Chen
,
et al
Added:
1 month ago
Toufan Bahrami
Research Area(s) / Expertise:
Job title: Consultant in Cardiac Surgery, Harefield Hospital, London, UK
Author
Author(s):
Ling-cong Kong
,
Tian Shuang
,
Yu-min Sun
,
et al
Added:
2 months ago
Author(s):
Kars Neven
,
Anna Füting
,
Stefan Hartl
,
et al
Added:
4 months ago
Author(s):
Serge Boveda
,
Andrea Sarkozy
Added:
4 weeks ago
In the latest episode of Arrhythmia Academy’s Journal Club, Dr Serge Boveda (Clinic Pasteur, FR) is joined by Professor Andrea Sarkozy (Brussels South University Hospital, BE) to explore the evolving role of pulsed field ablation (PFA) in the treatment of ventricular arrhythmias.The discussion focuses on the potential of PFA as a novel energy source in the ventricle, examining its ability to…
View more
Author(s):
Óscar Cano
,
Jeremy P Moore
Added:
1 year ago
Added:
3 days ago
Source:
Arrhythmia Academy
Pulsed field ablation (PFA) is an emerging energy source for atrial fibrillation (AF) ablation, noted for its promising safety profile. A large, real-world study, MANIFEST-US, has provided extensive data on the safety and utilisation of the pentaspline PFA catheter in the United States.¹Mechanism of ActionPFA is a non-thermal ablation modality that uses pulsed electric fields to create lesions…
View more
ICE in LAAO
Author(s):
Juan Carlos Diaz
,
Mauricio Duque
,
Jorge Marin
,
et al
Added:
1 year ago
Article
Added:
3 days ago
Source:
Arrhythmia Academy
A new substudy of the VANISH2 trial suggests that for patients with prior myocardial infarction and ventricular tachycardia (VT) who are eligible for sotalol, catheter ablation leads to better outcomes than antiarrhythmic drug (AAD) therapy.¹ For patients eligible only for amiodarone, efficacy was comparable, but amiodarone was associated with a significant increase in adverse events…
View more